rxstat › Classes › Other Urologicals, Incl Antispasmodics

Other Urologicals, Incl Antispasmodics: shortage status in Canada

11 of the 14 other urologicals, incl antispasmodics rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Alprostadil (Muse) Widespread shortage 3 of 5 reported products affected Flavoxate (Urispas) Widespread shortage 2 of 2 reported products affected Darifenacin (Enablex) Partial shortage 1 of 6 reported products affected Fesoterodine (Toviaz) Partial shortage 1 of 4 reported products affected · est. return Sep 18, 2026 Oxybutynin Chloride (Ditropan Xl) Partial shortage 2 of 11 reported products affected Phenazopyridine (Pyridium) Partial shortage 1 of 2 reported products affected Solifenacin (Vesicare) Partial shortage 5 of 25 reported products affected Tadalafil (Adcirca) Partial shortage 2 of 45 reported products affected · est. return Sep 18, 2026 Tolterodine (Detrol La) Partial shortage 5 of 16 reported products affected Trospium Chloride (Trosec) Partial shortage 1 of 2 reported products affected · est. return Dec 31, 2026 Vardenafil (Levitra) Partial shortage 2 of 14 reported products affected · est. return Oct 13, 2026 Dimethyl Sulfoxide (Rimso-50) Shortage anticipated 0 of 1 reported products affected Oxybutynin (Oxytrol) Discontinued 0 of 1 reported products affected Yohimbine Discontinued 0 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.